Answers are grounded in this paper and cite their sources.
Radiation-induced oral mucositis (RIOM) develops in approximately 80% of patients receiving radiotherapy for head and neck cancer, rising towards 100% with altered fractionation, and reaches grade 3 or 4 severity in around 56%. It causes pain, dysphagia, weight loss and secondary infection, and can interrupt treatment. A wide range of interventions has been investigated in both animal models and patients, yet none is recognised as a standard of care, and the two bodies of evidence have accumulated separately, with differing outcome measures, intervention types and study designs. This scoping review maps the prophylactic and therapeutic interventions evaluated for RIOM in preclinical and clinical studies published between January 2016 and September 2026, describes the outcomes and assessment instruments reported in each, and characterises the correspondence between them. PubMed, Scopus and the Cochrane Library will be searched. Methodological quality will be appraised using the SYRCLE Risk of Bias tool for animal studies and the Cochrane Risk of Bias 2 tool for randomised controlled trials. Findings will be synthesised narratively and reported following PRISMA-ScR.
No takes yet. Share an insight, caveat, or question.
Raja et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: